DiaCarta Launches OTC at Home Fecal Occult Blood Test to Complement its ColoScape™ Test

PLEASANTON, Calif., Dec. 5, 2023 /PRNewswire/ — DiaCarta, Inc., a leading innovator in precision medicine diagnostic biomarker assays, announced today that DiaCarta received US FDA 510(k) clearance for it’s over the counter (OTC) at home iColon Fecal Occult Blood Test (FOBT) that enables…

Click here to view original post